Rare diseases
Investigational molecules
Locations
459 conditions with trials, the busiest first
1 397 trials across Europe, recruiting first
Testing Tuvusertib in Patients with Returning IDH and ATRX Mutant Astrocytoma Brain Tumor
SpainA Study to Test the Safety and Effectiveness of TAK-360 in People with Narcolepsy without Cataplexy
FranceA Study Testing AOC 1020 to Improve Movement in Adults with Facioscapulohumeral Muscular Dystrophy
DenmarkA Study of Repinatrabit Compared to Placebo for Treatment of Patients with Phenylketonuria
CzechiaVorasidenib for patients with IDH-mutant grade 2 or 3 astrocytoma after completing first-line chemoradiotherapy
AustriaA Study of Gene Replacement Therapy for Children with CTNNB1 Syndrome Using Adeno-Associated Viral Vector Serotype 9 Containing the Human CTNNB1 Gene
SloveniaA Study Testing Cabergoline to Prevent and Treat Episodic Migraine in Patients with Recurring Migraine Headaches
DenmarkA Study of ACP-204 Tartrate for Adults With Lewy Body Dementia Psychosis
BulgariaA Study of TGD001 in Patients with Acute Ischemic Stroke to Test Safety and Effectiveness
GermanyA Study Testing ACP-204 Tartrate Compared to Placebo for Adults with Lewy Body Dementia Psychosis
BulgariaStudy of Lisocabtagene Maraleucel as First Treatment for Adults with Primary Central Nervous System Lymphoma Who Cannot Have a Stem Cell Transplant
FranceA Study of fesoterodine and 5-[(1R,5R)-3-Azabicyclo[3.
BulgariaThe therapies tested most often in Nervous system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
